Skip to main content
Premium Trial:

Request an Annual Quote

MDS, Blending In Molecular Devices, Nearly Doubles Analytics Sales in Q3

NEW YORK (GenomeWeb News) — MDS today yesterday reported that third-quarter revenue for the segment comprising its MDS Sciex and Molecular Devices units increased 92 percent as organic receipts rose 11 percent and R&D spending doubled.
 
Total revenue for the three months ended July 31 increased to $127 million from $66 million for its MDS Analytical Technologies segment, which includes Sciex and Molecular Devices.
 
Molecular Devices contributed $55 million and the Sciex division added $72 million in revenue.
 
Much of the growth came from the Molecular Devices division, which MDS acquired in March, and the company said growth in its Sciex business was strong, particularly in the small-molecule business.  
  
MDS did not break out its balance sheet or segment earnings for the quarter.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.